ABCC2 and colonic neoplasm: ABCC2 is considered to play a significant role in the resistance of colon cancer to platinum derivatives since it can effectively export glutathione-cisplatin conjugates, and in colon cancer cells, expression of multidrug resistance protein (MRP2 or ABCC2) was found significantly higher following cisplatin treatment [333, 334].